OnCusp Therapeutics Welcomes Dr. Dimitry Nuyten as Chief Medical Officer OnCusp Therapeutics has appointed Dr. Dimitry Nuyten as its Chief Medical Officer, signaling a strategic move to drive clinical development and innovation.

OnCusp Therapeutics Welcomes Dr. Dimitry Nuyten as Chief Medical Officer #United_States #Princeton #OnCusp_Therapeutics #CUSP06 #Dimitry_Nuyten